Cocaine Use Disorders Completed Phase 2 Trials for Selegiline (DB01037)

Also known as: Cocaine Use Disorder

IndicationStatusPhase
DBCOND0032361 (Cocaine Use Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01495195Combined Donepezil and Selegiline Effects on Cocaine-Reinforced BehaviorTreatment